Dr Reddy's launches lipid controlling drug in USA market

Pharma major Dr Reddy's Laboratories today said it has launched Fenofibrate capsules, a therapeutic equivalent generic version of Antara capsules, in the USA market.

The drug which is indicated to reduce cholesterol and triglycerides (fatty acids) in the blood was approved by the United States Food & Drug Administration (USFDA), DRL said in a statement.

The Antara (fenofibrate) capsules brand and generic had U.S. Sales of approximately $74 Million MAT for the most recent twelve months ending in February 2014 according to IMS Health.

Dr Reddy’s Fenofibrate capsules, USP 43 mg is available in bottle counts of 30, and 130 mg are available in bottle counts of 30 and 90, the drug maker said.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • RBI must keep a strict vigil on private debt inflows

    A little over a year ago, RBI governor Raghuram Rajan had observed that central banks of the developed world were excessively liberal with printing mo

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Tushar Gandhi

When too little could mean too late

The calamity in Jammu and Kashmir has once again shown ...

Purnendu Ghosh

Why art and science are natural partners

Art is qualitative and is generally associated with emotions. Science ...

Shona Adhikari

A toast to established and emerging talent

This week, our focus is on upcoming exhibitions in the ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture